Company Registration No. 14156835 (England and Wales)
Mattia Basili Cardiology Limited
Unaudited accounts
for the year ended 30 June 2026
Mattia Basili Cardiology Limited
Unaudited accounts
Contents
Mattia Basili Cardiology Limited
Company Information
for the year ended 30 June 2026
Company Number
14156835 (England and Wales)
Registered Office
42 Gladstone Avenue Gladstone Avenue
Chester
CH1 4JU
Accountants
Taxez
5 South Charlotte Street
Edinburgh
EH2 4AN
Mattia Basili Cardiology Limited
Statement of financial position
as at 30 June 2026
Cash at bank and in hand
29,991
10,705
Creditors: amounts falling due within one year
(18,269)
(7,886)
Net current assets
58,548
29,600
Called up share capital
1
1
Profit and loss account
58,547
30,242
Shareholders' funds
58,548
30,243
For the year ending 30 June 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 30 July 2026 and were signed on its behalf by
Dr Mattia Basili
Director
Company Registration No. 14156835
Mattia Basili Cardiology Limited
Notes to the Accounts
for the year ended 30 June 2026
Mattia Basili Cardiology Limited is a private company, limited by shares, registered in England and Wales, registration number 14156835. The registered office is 42 Gladstone Avenue Gladstone Avenue, Chester, CH1 4JU.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. Turnover from the sale of goods is recognised when goods have been delivered to customers such that risks and rewards of ownership have transferred to them. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Computer equipment
25% Straight line
4
Tangible fixed assets
Computer equipment
Mattia Basili Cardiology Limited
Notes to the Accounts
for the year ended 30 June 2026
Amounts falling due within one year
Other debtors
10,736
10,736
6
Investments held as current assets
2026
2025
Listed investments
36,090
16,045
7
Creditors: amounts falling due within one year
2026
2025
Taxes and social security
6,812
615
Loans from directors
11,038
6,912
8
Average number of employees
During the year the average number of employees was 1 (2025: 1).